tirzepatide weight regain study Loss Drugs Part 3 Shifting the Scales: Tirzepatide's Breakthrough

READ MORE: How Oura Data Can Help You Understand Your Menstrual Cycle

Direct-to-Consumer Cash Pricing (For Uninsured/Self-Pay Patients) For patients without insurance coverage or who choose to pay cash, the new pricing structure provides: Introductory offer: $199 per month for the first two months (0.25mg and 0.5mg doses)

Paired with our Weight Loss Program, our patients have lost, on average, 20 lbs in three months

Research-Use Only Compliance All products are labeled For Research Use Only Not for Human Consumption. This ensures your lab maintains proper compliance for formulation or cosmetic R&D

The FDA-approved Wegovy escalation Weeks 1 through 4: 0.25 mg once weekly